Team-Based Shared Decision-Making Program in Cardiovascular-Kidney-Metabolic Health (Healthy Heart - CKM)

Study acronym: SDM in CKM
StatusNot Yet Recruiting
PhaseEarly Phase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date pushed from Sep 30, 2026 to Oct 30, 2026
    • Eligibility criteria shortened, about 29 words
    • Study title expanded, about 4 words
  2. Primary endpoints: details revised at 1 of 1 entry
    • Start date: Sep 10, 2026 to Sep 30, 2026
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 5 of 5 entries
  3. Start date: Aug 10, 2026 to Sep 10, 2026v4
  4. Start date: Jul 1, 2026 to Aug 10, 2026v3
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Johns Hopkins University
509 trials monitored
See 41 trials at risk
Diabetes
5,101 trials monitored
See 233 trials at risk
Obesity
3,888 trials monitored
See 157 trials at risk
Hypertension
1,933 trials monitored
See 101 trials at risk
The investigators are proposing a new team-based shared decision-making (SDM) program. The goal of this study is to see whether this program is practical and whether it may help adults with cardiometabolic risk factors and cardiovascular-kidney-metabolic syndrome. The investigators will enroll adults from a primary care clinic in Maryland. People in the intervention group will take part in the 6-month program in addition to usual care. People in the control group will receive usual care only.
Trial Details
NCT Number NCT07662616
Lead Sponsor Johns Hopkins University
Conditions
(from sponsor)		 Hypertension (HTN), Diabetes (DM), Hyperlipidaemia, Kidney Disease, Obesity, Cardiovascular-kidney-metabolic (CKM), Overweight
Related terms Diabetes Mellitus, Hyperlipidemias, Hypertension, Kidney Diseases, Obesity, Overweight
Enrollment 94 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov